KwiatkowskiT.G.LibmanR.B.FrankelM.Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med1999; 340:1781–7.
2.
DerexL.AdeleineP.NighoghossianN.HonnoratJ.TrouillasP.Factors influencing early admission in a French stroke unit. Stroke2002; 33:153–9.
3.
MorgensternL.B.BartholomewL.K.GrottaJ.C.StaubL.KingM.ChanW.Sustained benefit of a community and professional intervention to increase acute stroke therapy. Arch Intern Med2003; 163:2198–202.
4.
HackeW.KasteM.BluhmkiE.Thrombolysis with alteplase 3 to 4·5 hours after acute ischemic stroke. N Engl J Med2008; 359:1317–29.
5.
DirksM.NiessenL.W.Van WijngaardenJ.The effectiveness of thrombolysis with intravenous alteplase for acute ischemic stroke in daily practice. Int J Stroke2012; 7:289–92.
